H. Arak and T. Kuş, “Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”, Eur J Ther, vol. 30, no. 5, pp. 662–674, May 2024.